BeOne Medicines
688235----
Q2 2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: BeOne Medicines(688235) the Revenue is 11.58 B (+22.87%), Beat estimate;the EBIT is 2.207 B (+250.6%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
11.58B22.87%
10.99B16.65%
+0.59B6.22%
EBITExceed expectations
2.21B250.56%
1.55B146.90%
+0.65B103.66%
Upcoming earnings report - Q3 FY2026
Available dateNov 5, 2026
Estimate Revenue¥11.73 B
Estimate EBIT--
Estimate EPS--
Revenue
ActualEstimateUnit: CNY
Quarterly
EBIT
ActualEstimateUnit: CNY
Quarterly
Net income
ActualEstimateUnit: CNY
Quarterly
EPS
ActualEstimateUnit: CNY
Quarterly